RxDoctor Payments Data

Leslie Stapp, DO

Dermatology · Great Falls, MTNPI 1154380020

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $47,969 of the $57,875 with a category attached, or 82.9%. Amgen accounts for 67.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $16,540 and has fallen 88.3% since, to $1,931 in 2025. Among dermatology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,875in general payments, 2019–2025

Across 304 payments — averaging $190.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$39K
  • Bristol Myers Squibb$8K
  • Pfizer$6K
  • AbbVie$1K
  • Biofrontera Inc.$755
  • E.r. Squibb & Sons, L.L.C.$552
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$4581%
  • Speaking & faculty fees$47,96983%
  • Travel & lodging$3,0925%
  • Food & beverage$6,35611%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,875 in reported general payments places this provider in the 95th percentile of 46 dermatology providers in Montana.

See all dermatology providers in Montana

Medicare billing

Part B allowed, 2024
$91,480
Medicare patients
499
Services billed
1,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab27$101,839
Taltz AutoinjectorIxekizumab12$73,395
Clobetasol Propionate50$2,850
Tacrolimus13$1,896
Ketoconazole66$1,118
Triamcinolone Acetonide56$623
Nystatin18$258
Spironolactone11$144
Glycopyrrolate12$88
Prednisone14$63

Paid to pharmacies, not to this prescriber.

Other dermatology in Great Falls

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →